Haier Biomedical plans to use oversubscribed funds to supplement working capital and launch a new employee stock ownership plan.

Zhongfang Network Data
Qingdao Haier Biomedical Co., Ltd. held the tenth meeting of its third board of directors on March 27, 2026, where several important proposals were reviewed and approved. In terms of finance, the company’s financial settlement report for 2025 was approved, and it plans to use part of the oversubscription funds amounting to 47 million yuan to permanently supplement its working capital to improve capital efficiency. At the same time, the board agreed to use temporarily idle raised funds not exceeding 50 million yuan and idle self-owned funds not exceeding 2.7 billion yuan for cash management to increase capital returns.

In terms of incentives and governance, the company has introduced a draft employee stock ownership plan for 2026, aimed at establishing a profit-sharing mechanism to attract and retain core talent. The board also reviewed and approved the shareholder dividend return plan for the next three years and plans to revise the “Articles of Association” and related governance systems to improve the company’s governance structure. In addition, the company plans to cancel a total of 2.6525 million shares of stock that were granted but not vested from the restricted stock incentive plan for 2024.

Regarding related party transactions and auditing, the company has estimated the daily related party transaction limits for 2026 and has decided to reappoint Ernst & Young Hua Ming Accounting Firm as the company’s auditing institution for 2026. To mitigate foreign exchange risk, the company has been approved to conduct foreign exchange hedging business not exceeding 100 million US dollars.

On the personnel front, the board nominated Mr. Liu Gang as the company’s candidate for co-CEO, pending formal duties after the relevant system revisions are approved by the shareholders’ meeting. The meeting also reviewed and approved the company’s 2025 annual report, sustainable development report, and the “Quality Improvement, Efficiency Enhancement, and Return Action Plan.”

The above proposals, including the use of oversubscription funds to supplement working capital, reappointment of the accounting firm, profit distribution plan, shareholder dividend return plan, employee stock ownership plan, revision of the “Articles of Association,” and purchasing liability insurance for directors and supervisors, still need to be submitted for approval at the company’s 2025 annual shareholders’ meeting. The company is scheduled to hold the annual shareholders’ meeting on April 24, 2026.

Massive information and precise interpretation are all available on the Sina Finance APP.